Yamaguchi Y, Harland R C, Wyble C, Bollinger R R
Department of Surgery, Duke University Medical Center, Durham, North Carolina 27710.
Transplantation. 1989 Jan;47(1):171-7. doi: 10.1097/00007890-198901000-00036.
In an attempt to study the role of class I major histocompatibility complex antigens in inducing immunological unresponsiveness, the survival rates of hepatic allografts were compared in rats pretreated with blood taken from various rat strains. A single intravenous injection of 1 ml fresh heparinized whole blood seven days before transplantation significantly prolonged the survival of subsequent donor-specific hepatic allografts in the fully allogeneic ACI(RT1a)-to-LEW(RT1l) rat combination. However, pretreatment with blood taken from the third-party strain BN(RT1n) did not produce suppression of rejection, attesting to the specificity of the pretransplant transfusion effect. Interestingly, pretransplant transfusion of PVG.r1 blood, sharing only the RT1.A MHC region with ACI, significantly prolonged the survival of ACI-to-LEW hepatic allografts. In addition, no lymphocytotoxic antibodies could be detected at 30 or 100 days after transplantation in animals with long-surviving hepatic allografts pretreated with either PVG.r1 or ACI whole blood. On the other hand, pretreatment with PVG(RT1c) blood increased the survival of ACI-to-LEW hepatic allografts only moderately compared with controls. This finding may be consistent with a partial effect of some third-party blood transfusion. The experimental data suggest that the class I MHC antigens can be immunosuppressive in rat hepatic allografts. Adoptive transfer of 5 x 10(7) splenocytes taken from long-term-surviving hepatic allografts pretreated with donor ACI whole blood or PVG.r1 blood into irradiated (750 rads) LEW rats prolonged the survival of donor-type skin grafts, whereas third-party strain (BN) grafts were rejected. This finding suggests the presence of donor-specific suppressor cells.
为了研究I类主要组织相容性复合体抗原在诱导免疫无反应性中的作用,比较了用来自不同大鼠品系的血液预处理的大鼠肝同种异体移植物的存活率。在移植前7天单次静脉注射1 ml新鲜肝素化全血,可显著延长完全同种异体的ACI(RT1a)至LEW(RT1l)大鼠组合中后续供体特异性肝同种异体移植物的存活时间。然而,用来自第三方品系BN(RT1n)的血液进行预处理并未产生排斥反应的抑制作用,这证明了移植前输血效应的特异性。有趣的是,仅与ACI共享RT1.A MHC区域的PVG.r1血液的移植前输血显著延长了ACI至LEW肝同种异体移植物的存活时间。此外,在用PVG.r1或ACI全血预处理的具有长期存活肝同种异体移植物的动物中,在移植后30天或100天未检测到淋巴细胞毒性抗体。另一方面,与对照组相比,用PVG(RT1c)血液预处理仅适度提高了ACI至LEW肝同种异体移植物的存活率。这一发现可能与某些第三方输血的部分效应一致。实验数据表明,I类MHC抗原在大鼠肝同种异体移植中可能具有免疫抑制作用。将取自用供体ACI全血或PVG.r1血液预处理的长期存活肝同种异体移植物的5×10⁷个脾细胞过继转移到经照射(750拉德)的LEW大鼠中,可延长供体型皮肤移植物的存活时间,而第三方品系(BN)的移植物则被排斥。这一发现表明存在供体特异性抑制细胞。